Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S.
Manufacturing
CSL earmarks $1.5B for US production expansion over next 5 years
The company will spend approximately $1.5 billion in capital investments to grow its U.S. plasma manufacturing capabilities over the next five years.
Zoey Becker
Nov 18, 2025 7:56am
Gilead tees up $11B in new US manufacturing, R&D investments
May 8, 2025 6:25am
Endo recalls 1 lot of panic disorder drug due to labeling issue
Jul 17, 2024 11:32am
WuXi AppTec allegedly handed over client's IP to China: report
Mar 28, 2024 10:21am
US bulks up supply of Amgen's radiation sickness med Nplate
Oct 5, 2022 11:09am
White House cross with Moderna about COVID-19 donations
Oct 7, 2021 12:59pm
